KR20090128479A - 암 치료를 위한 경요도 절제술 후 방광내 아파지퀀 투여 - Google Patents
암 치료를 위한 경요도 절제술 후 방광내 아파지퀀 투여 Download PDFInfo
- Publication number
- KR20090128479A KR20090128479A KR1020097021277A KR20097021277A KR20090128479A KR 20090128479 A KR20090128479 A KR 20090128479A KR 1020097021277 A KR1020097021277 A KR 1020097021277A KR 20097021277 A KR20097021277 A KR 20097021277A KR 20090128479 A KR20090128479 A KR 20090128479A
- Authority
- KR
- South Korea
- Prior art keywords
- tur
- bladder
- cancer
- apaziquine
- therapeutic composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89461007P | 2007-03-13 | 2007-03-13 | |
| US60/894,610 | 2007-03-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20090128479A true KR20090128479A (ko) | 2009-12-15 |
Family
ID=39494173
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020097021277A Ceased KR20090128479A (ko) | 2007-03-13 | 2008-03-13 | 암 치료를 위한 경요도 절제술 후 방광내 아파지퀀 투여 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20080227841A1 (enExample) |
| EP (1) | EP2134322B1 (enExample) |
| JP (2) | JP5788143B2 (enExample) |
| KR (1) | KR20090128479A (enExample) |
| CN (1) | CN101677942B (enExample) |
| AR (1) | AR065732A1 (enExample) |
| AU (1) | AU2008224962B2 (enExample) |
| BR (1) | BRPI0808804A2 (enExample) |
| CA (1) | CA2680481C (enExample) |
| ES (1) | ES2727257T3 (enExample) |
| IL (1) | IL200899A0 (enExample) |
| MX (1) | MX2009009777A (enExample) |
| NZ (1) | NZ579609A (enExample) |
| RU (2) | RU2480200C2 (enExample) |
| TW (1) | TWI434684B (enExample) |
| WO (1) | WO2008112934A1 (enExample) |
| ZA (1) | ZA200906328B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201213486D0 (en) * | 2012-07-30 | 2012-09-12 | Univ Salford The | Quinone compounds and their uses for the treatment of cancer |
| WO2014062856A1 (en) | 2012-10-16 | 2014-04-24 | Halozyme, Inc. | Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2178305C1 (ru) * | 2000-11-02 | 2002-01-20 | Гарбер Александр Григорьевич | Ирригационный раствор |
| ATE493126T1 (de) * | 2001-11-01 | 2011-01-15 | Spectrum Pharmaceuticals Inc | Medizinische zusammensetzungen zur intravesikalen behandlung von blasenkrebs |
| RU2002121829A (ru) * | 2002-08-07 | 2004-02-27 | Сгму | Способ лечения местнораспространенных форм рака мочевого пузыря |
-
2008
- 2008-03-13 BR BRPI0808804-7A patent/BRPI0808804A2/pt not_active Application Discontinuation
- 2008-03-13 KR KR1020097021277A patent/KR20090128479A/ko not_active Ceased
- 2008-03-13 ES ES08732162T patent/ES2727257T3/es active Active
- 2008-03-13 NZ NZ579609A patent/NZ579609A/en not_active IP Right Cessation
- 2008-03-13 JP JP2009553789A patent/JP5788143B2/ja not_active Expired - Fee Related
- 2008-03-13 RU RU2009137770/15A patent/RU2480200C2/ru not_active IP Right Cessation
- 2008-03-13 AU AU2008224962A patent/AU2008224962B2/en not_active Ceased
- 2008-03-13 US US12/048,178 patent/US20080227841A1/en not_active Abandoned
- 2008-03-13 WO PCT/US2008/056912 patent/WO2008112934A1/en not_active Ceased
- 2008-03-13 CN CN2008800159754A patent/CN101677942B/zh not_active Expired - Fee Related
- 2008-03-13 CA CA2680481A patent/CA2680481C/en not_active Expired - Fee Related
- 2008-03-13 MX MX2009009777A patent/MX2009009777A/es active IP Right Grant
- 2008-03-13 EP EP08732162.6A patent/EP2134322B1/en not_active Not-in-force
- 2008-03-13 TW TW097108857A patent/TWI434684B/zh not_active IP Right Cessation
- 2008-03-14 AR ARP080101046A patent/AR065732A1/es not_active Application Discontinuation
-
2009
- 2009-09-11 ZA ZA200906328A patent/ZA200906328B/xx unknown
- 2009-09-13 IL IL200899A patent/IL200899A0/en active IP Right Grant
-
2012
- 2012-12-26 RU RU2012157329A patent/RU2623142C2/ru not_active IP Right Cessation
-
2013
- 2013-09-30 JP JP2013203128A patent/JP2014028841A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP2134322A1 (en) | 2009-12-23 |
| CN101677942A (zh) | 2010-03-24 |
| TW200904410A (en) | 2009-02-01 |
| US20080227841A1 (en) | 2008-09-18 |
| CA2680481C (en) | 2016-06-21 |
| NZ579609A (en) | 2012-01-12 |
| CA2680481A1 (en) | 2008-09-18 |
| WO2008112934A1 (en) | 2008-09-18 |
| AU2008224962B2 (en) | 2013-07-25 |
| ES2727257T3 (es) | 2019-10-15 |
| BRPI0808804A2 (pt) | 2014-08-19 |
| MX2009009777A (es) | 2009-11-26 |
| AU2008224962A1 (en) | 2008-09-18 |
| JP2014028841A (ja) | 2014-02-13 |
| ZA200906328B (en) | 2010-05-26 |
| RU2480200C2 (ru) | 2013-04-27 |
| RU2012157329A (ru) | 2014-07-10 |
| EP2134322B1 (en) | 2019-02-20 |
| RU2623142C2 (ru) | 2017-06-22 |
| JP5788143B2 (ja) | 2015-09-30 |
| JP2010521488A (ja) | 2010-06-24 |
| TWI434684B (zh) | 2014-04-21 |
| AR065732A1 (es) | 2009-06-24 |
| IL200899A0 (en) | 2010-05-17 |
| RU2009137770A (ru) | 2011-04-20 |
| CN101677942B (zh) | 2013-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2002022163A1 (en) | Remedies for ischemic diseases | |
| KR20190035776A (ko) | 5-콜레스텐-3, 25-디올, 3-술페이트 (25hc3s) 또는 이의 약학적으로 허용 가능한 염, 및 적어도 하나의 시클릭 올리고당을 포함하는 조성물 | |
| JP2004515453A (ja) | 癌を化学療法および放射線療法に付する間に細胞を保護するための組成物および方法 | |
| KR20210053948A (ko) | 겸상 세포 질환의 치료를 위한 pde9 억제제 | |
| US20150190413A1 (en) | Compositions and methods for the treatment of bladder cancer | |
| US20090036527A1 (en) | Therapeutic Application Of Leonurine In Treating Cardiomyopathy | |
| EP3968997A1 (en) | Treatment of cutaneous lupus erythematosus | |
| KR20090128479A (ko) | 암 치료를 위한 경요도 절제술 후 방광내 아파지퀀 투여 | |
| US10857191B2 (en) | Sandalwood oil and its uses related to oral mucositis | |
| WO2022036111A1 (en) | Methods and compositions for treating sickle cell disease | |
| EP4556472A1 (en) | Use of pyridone derivative | |
| JP4020256B2 (ja) | 前立腺癌の局所治療剤 | |
| CN114686417A (zh) | 高效抑制肝癌的细胞囊泡制剂、其制备方法及其应用 | |
| EP4321160A1 (en) | Compound for preventing or treating diabetes | |
| CN107050025A (zh) | 樟柳碱在制备预防或治疗肾纤维化的药物中的应用 | |
| JP2004231557A (ja) | エピネフリン含有抗腫瘍剤 | |
| Cerny et al. | Subcutaneous continuous infusion of ifosfamide and cyclophosphamide in ambulatory cancer patients: bioavailability and feasibility | |
| CN104394874A (zh) | 用于治疗动脉硬化性血管病的方法和组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20091012 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20130312 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20140328 Patent event code: PE09021S01D |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20141027 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20150422 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20141027 Comment text: Notification of reason for refusal Patent event code: PE06011S01I Patent event date: 20140328 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |
|
| J201 | Request for trial against refusal decision | ||
| PJ0201 | Trial against decision of rejection |
Patent event date: 20150526 Comment text: Request for Trial against Decision on Refusal Patent event code: PJ02012R01D Patent event date: 20150422 Comment text: Decision to Refuse Application Patent event code: PJ02011S01I Appeal kind category: Appeal against decision to decline refusal Appeal identifier: 2015101002918 Request date: 20150526 |
|
| J301 | Trial decision |
Free format text: TRIAL NUMBER: 2015101002918; TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20150526 Effective date: 20161027 |
|
| PJ1301 | Trial decision |
Patent event code: PJ13011S01D Patent event date: 20161027 Comment text: Trial Decision on Objection to Decision on Refusal Appeal kind category: Appeal against decision to decline refusal Request date: 20150526 Decision date: 20161027 Appeal identifier: 2015101002918 |